SCHEMBL3402916

SCHEMBL3402916

CCCC(=O)/C=C/c1ccc(F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 3/20 0.63
TRPA1 O75762 2/20 0.61
HSD11B1 P28845 1/20 0.58
TNFRSF1A P19438 1/20 0.53
RAB9A P51151 4/20 0.51
KMT2A Q03164 1/20 0.51
MAOB P27338 2/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 1/20 0.50
NPC1 O15118 3/20 0.49
APP P05067 1/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
HTT P42858 1/20 0.49
MAOA P21397 1/20 0.49
SLC5A1 P13866 1/20 0.49
SLC5A2 P31639 1/20 0.49
BACE1 P56817 1/20 0.49
POLB P06746 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3402919 1.00 IAPP (0.63) IAPPTRPA1HSD11B1TNFRSF1ARAB9A
SCHEMBL3399802 0.90 IAPP (0.65) IAPPTRPA1HSD11B1TNFRSF1ARAB9A
SCHEMBL3399806 0.90 IAPP (0.65) IAPPTRPA1HSD11B1TNFRSF1ARAB9A
SCHEMBL3401728 0.85 HSD11B1 (0.62) IAPPTRPA1HSD11B1TNFRSF1AKMT2A
SCHEMBL3401725 0.85 HSD11B1 (0.62) IAPPTRPA1HSD11B1TNFRSF1AKMT2A
SCHEMBL20273252 0.84 RAB9A (0.72) IAPPRAB9AKMT2AMAOBNPC1
SCHEMBL28417654 0.84 HSD11B1 (0.60) TRPA1HSD11B1TNFRSF1ARAB9AKMT2A
SCHEMBL27832637 0.84 RAB9A (0.72) IAPPRAB9AKMT2AMAOBNPC1
SCHEMBL19236353 0.84 IAPP (0.70) IAPPHSD11B1RAB9AKMT2AMAOB
SCHEMBL14875147 0.83 HSD11B1 (0.69) HSD11B1TNFRSF1AKMT2AMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108905-B2 TRPA1 antagonists ABBVIE INC. (US) 2015-08-18 US disclosed
EP-2249820-A1 TRPA1 ANTAGONISTS Abbott Laboratories (US) 2010-11-17 EP disclosed
WO-2009089082-A1 TRPA1 ANTAGONISTS ABBOTT LABORATORIES (US) 2009-07-16 WO disclosed
US-20090176883-A1 TRPA1 Antagonists ABBOTT LABORATORIES (US) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176883-A1 TRPA1 Antagonists TRPA1, TRPV1, TRPV3 IAPP 812/4885TRPA1 1/4885HSD11B1 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.